Light Mode
$15.29 ↑ +0.00 (+0.00%) Trading Up from the previous close of $15.29, $0.01 below the day’s high of $15.30
+5.70 (+59.44%) / 6M
Momentum, market sentiment, and recent alerts
BHVN reads very good: price sits above both the 20- and 200-day averages, short interest is falling month over month, the 12-month move is -12.1%.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
Biohaven Ltd. is a global clinical stage biopharmaceutical company, which engages in the discovery, development, and commercialization of therapies for people with neurological and neuropsychiatric diseases. The company was founded on May 2, 2022 and is headquartered in New Haven, CT.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.